Kidney cancer, Renal cell cancer
Results
Phase 3
This trial looked at using the drugs fluorouracil, interleukin 2 and interferon alpha after surgery to see if they could help improve the treatment outcome for kidney cancer. This trial was supported by Cancer Research UK.
Recruitment start: 29 May 1998
Recruitment end: 21 March 2007
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Michael Aitchinson
Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/98/004.
Last reviewed: 20 September 2012
CRUK internal database number: 62